The device, which gained CE mark approval in Europe in May 2021, features a new-look fabric cuff designed to keep the risk of paravalvular leak (PVL) at a minimum.

Shockwave Medical's decision to acquire Neovasc is based largely on the potential of the Neovasc Reducer System, a solution designed to treat the symptoms of refractory angina by altering a patient's blood flow.

Primary aldosteronism (PA) is one the single most common causes of hypertension, but identifying patients with PA—and knowing which ones may benefit from a surgical treatment—can be quite challenging.

"These findings provide further insight into the positive effects of the DASH diet ... and highlight the need for public health policies and interventions that support sustained adherence to a healthy eating pattern," researchers wrote. 

Researchers evaluated if two recently developed risk scores can anticipate adverse in-hospital outcomes after PCI, sharing their findings in the American Journal of Cardiology.

The partnership is with ScImage, a California-based healthcare technology company known for its extensive EI background.

The Kentucky physician fought back against the allegations, but his attorney's arguments were not effective enough to sway the judge. 

A new analysis in Circulation: Cardiovascular Interventions examined rehospitalization rates after AVR, noting that they are consistently associated with worse outcomes and a higher risk of patient mortality.

The uninsured rate in the United States saw a drop from 11.1% in 2019 to 10.5% in 2021, according to a new report from the Department of Health and Human Services (HHS).

The growing presence of non-physician practitioners has created an increased demand for contrast-enhanced imaging, according to new data.